| Serial Number | 97220299 |
| Word Mark | DIAMOND |
| Filing Date | Friday, January 14, 2022 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Saturday, April 1, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Pharmaceutical preparations and therapeutic pharmaceuticals for the treatment of neurological diseases and disorders, central nervous system diseases and disorders, neurodegenerative diseases and disorders, immune system-related diseases and disorders, and metabolic diseases and disorders |
| Goods and Services | Software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images, information and artificial intelligence in the fields of drug discovery and healthcare, biomedical and genomic research; software featuring machine learning and artificial intelligence for data analysis in the fields of drug discovery and healthcare, biomedical and genomic research; software featuring machine learning and artificial intelligence for drug analysis in drug discovery and development; software incorporating artificial intelligence and machine learning models for collecting, analyzing, assessing, interpreting and predicting medical, health, transcriptional, genetic, genomic, pharmacogenomic, nutrigenomic, microbiomic, metabolomic, proteomic, biochemistry, and biomarker information, associations, conditions, outcomes, effects and risks; software for genetic assessment and identification of cancer, diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; software for collecting, analyzing, reporting, and tracking data and information in the fields of drug discovery and development, genetics, genomics, biology, biochemistry; software for collecting, analyzing, reporting, and tracking data and information in the fields of clinical trial management and patient engagement; scientific research, namely, research and analysis services featuring artificial intelligence and machine learning analytics in the fields of healthcare, biomedical and genomic research; research and development in the field of drug discovery and development, computational biology, bioinformatics, and genomics; research and development of pharmaceutical preparations and therapeutic pharmaceuticals for the treatment of neurological diseases and disorders, central nervous system diseases and disorders, neurodegenerative diseases and disorders, immune system-related diseases and disorders, and metabolic diseases and disorders; technical scientific consultation and product development for others in the fields of drug discovery and development, pharmaceuticals, biotechnology and immunology; consulting in the fields of drug discovery and development, clinical trial management and patient engagement in drug clinical trials |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 18, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 18, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Vesalius Therapeutics Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02139 |
| Event Date | Event Description |
| Monday, April 3, 2023 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Saturday, April 1, 2023 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Saturday, April 1, 2023 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Wednesday, September 14, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, September 14, 2022 | NON-FINAL ACTION E-MAILED |
| Wednesday, September 14, 2022 | NON-FINAL ACTION WRITTEN |
| Thursday, August 18, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, August 17, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, August 17, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, July 8, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, July 8, 2022 | NON-FINAL ACTION E-MAILED |
| Friday, July 8, 2022 | NON-FINAL ACTION WRITTEN |
| Tuesday, July 5, 2022 | ASSIGNED TO EXAMINER |
| Friday, January 21, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |